Lower Extremity Ulcers — Arterial Venous Neuropathic

ARTERIAL ULCERS

• Atherosclerotic arterial insufficiency mechanism: Progressive obstruction of large and medium-sized arteries (aortoiliac, femoropopliteal, infrapopliteal vessels) by atherosclerotic plaque leads to critical limb ischemia when perfusion pressure falls below metabolic demands of tissue. Claudication pain occurs at reproducible distances during exertion; rest pain develops when resting oxygen delivery becomes inadequate. Ulceration occurs at sites of greatest mechanical stress and poorest collateralization (typically lateral malleolus, plantar pressure points, and distal digits). Acute-on-chronic arterial occlusion precipitates rapid tissue necrosis.

• Endothelial dysfunction and inflammation: Atherosclerosis involves progressive endothelial injury, lipoprotein oxidation, macrophage infiltration, and smooth muscle proliferation. Reduced endothelial nitric oxide production impairs vasodilation and permits platelet aggregation. Advanced atherosclerosis causes medial calcification and loss of arterial compliance, increasing pulse pressure and shear stress on remaining endothelium.

• Microvascular and collateral insufficiency: Chronic hypoxia triggers angiogenic signaling (VEGF, HIF-1α) but collateral development is often insufficient, especially in diabetics with impaired growth factor responsiveness. Microvascular rarefaction and capillary dropout further compromise tissue oxygen delivery. Inflammatory mediators (IL-6, TNF-α, CRP) perpetuate vascular damage.

VENOUS ULCERS

• Valvular incompetence and venous hypertension: Primary valve insufficiency (varicose veins, post-thrombotic damage) or calf muscle pump dysfunction permits sustained venous hypertension in dependent limbs, typically 40-90 mmHg during standing (normal: <20 mmHg). Ambulatory venous hypertension is transmitted retrogradely to capillaries, causing capillary distension, endothelial hypoxia, and increased capillary permeability. Sustained pressure leads to interstitial fibrin deposition, inflammation, and eventual tissue breakdown.

• Capillary dysfunction and white cell trapping: Venous hypertension causes red blood cell aggregation and capillary obstruction; white blood cells adhere to endothelium and migrate into tissue, releasing proteases (elastase, collagenase) and oxygen radicals that degrade extracellular matrix. Fibrin cuff formation around capillaries impairs oxygen diffusion. Growth factor sequestration by fibrin prevents healing.

• Inflammatory cascade and matrix degradation: Elevated cytokines (TNF-α, IL-1, IL-6), increased metalloproteinase (MMP-2, MMP-9) activity, and reduced tissue inhibitors of metalloproteinases (TIMPs) create a pro-inflammatory, catabolic wound environment. Chronic edema perpetuates this inflammatory state. Macrophage infiltration and lymphatic dysfunction further amplify inflammation.

NEUROPATHIC ULCERS

• Sensory denervation and loss of protective sensation: Diabetes mellitus and other peripheral neuropathies (syphilis, leprosy, Charcot-Marie-Tooth disease) cause axonal degeneration of large myelinated sensory fibers, resulting in loss of protective pain sensation. Patients sustain repetitive micro- and macro-trauma (pressure, heat, foreign bodies, blisters) without awareness. Unrecognized injury leads to callus formation, blister rupture, and progressive tissue breakdown, typically at high-pressure plantar sites (metatarsal heads, heel).

• Motor denervation and biomechanical abnormalities: Loss of intrinsic foot muscle innervation causes muscle atrophy and weakness, leading to abnormal foot mechanics and high focal pressure zones. Unopposed extensor function produces claw toe deformities and increased plantar pressures at metatarsal heads. Inability to sense pain prevents compensatory gait modification, perpetuating trauma.

• Autonomic dysfunction and impaired wound healing: Autonomic neuropathy causes loss of sudomotor function and skin drying, reducing barrier function and increasing risk of fissuring. Impaired microvascular autoregulation and reduced neovascularization in neuropathic tissue impair healing response. Hyperglycemia-induced advanced glycation end products (AGEs) crosslink collagen, reduce elasticity, and impair growth factor signaling, creating a chronically inflamed, poorly healing wound bed.

ARTERIAL ULCERS

Major causes

• Atherosclerotic peripheral arterial disease (PAD): Accounts for >90% of arterial ulcers; risk factors include smoking (strongest modifiable risk), diabetes, hypertension, hyperlipidemia, advancing age, male sex, and chronic kidney disease. Diabetes increases PAD risk 2-4 fold and accelerates atherosclerosis progression.
• Acute arterial occlusion: Thromboembolism (atrial fibrillation, atherosclerotic plaque rupture, aortic dissection), in-situ thrombosis, arterial trauma, or iatrogenic injury (catheterization, surgery)
• Vasculitis: Large-vessel (giant cell arteritis, Takayasu arteritis), medium-vessel (polyarteritis nodosa, Kawasaki disease), or small-vessel (ANCA-associated vasculitis, hypersensitivity vasculitis) inflammation
• Thrombophilia and hypercoagulable states: Antiphospholipid syndrome, factor V Leiden, prothrombin G20210A mutation, hyperhomocysteinemia
• Other causes: Fibromuscular dysplasia, radiation arteritis, ergotism, cocaine use (vasospasm), Raynaud's phenomenon with severe digital ischemia, cardiac embolism

Risk factors

• Age >60 years
• Smoking (dose-dependent; increases risk 10-fold)
• Diabetes mellitus (accelerates atherosclerosis; increases ulcer risk 2-3 fold)
• Hypertension
• Dyslipidemia
• Chronic kidney disease and end-stage renal disease
• Elevated inflammatory markers (CRP, fibrinogen)

VENOUS ULCERS

Major causes

• Primary venous insufficiency (varicose veins): Accounts for ~60% of venous ulcers; valve leaflet separation and annular dilation permit reflux. Saphenous vein incompetence (greater or lesser saphenous) is most common. Intrinsic valve abnormalities or vein wall weakness may be inherited.
• Post-thrombotic syndrome (PTS): Results from deep vein thrombosis (DVT) causing valve destruction, venous obstruction, and chronic venous hypertension. Risk increases with proximal DVT, inadequate anticoagulation, and recurrent thrombosis. PTS develops in 20-50% of DVT patients; ulceration occurs in ~5-10%.
• Popliteal vein entrapment syndrome: Rare; muscular or fibrous structures compress popliteal vein during knee flexion, predisposing to thrombosis and PTS

Risk factors

• Age >50 years
• Female sex (pregnancy and estrogen therapy increase risk 3-5 fold)
• Obesity
• Prolonged immobility or sedentary occupation
• History of DVT or thrombophilia
• Leg trauma or surgery
• Venous obstruction (malignancy, mass effect)
• Increased intra-abdominal pressure (cirrhosis, ascites, pregnancy)
• Lymphedema (impairs venous return)
• Family history of varicose veins

NEUROPATHIC ULCERS

Major causes

• Diabetes mellitus: Accounts for ~90% of neuropathic ulcers worldwide. Both type 1 and type 2 diabetes cause distal symmetric sensorimotor polyneuropathy through hyperglycemia-induced mechanisms (polyol pathway activation, oxidative stress, AGE accumulation, microvascular ischemia). Autonomic neuropathy causes sudomotor dysfunction and impaired microvascular regulation.
• Other peripheral neuropathies: Leprosy (Hansen's disease; most common cause globally outside diabetes), syphilis (tertiary), Charcot-Marie-Tooth disease, hereditary sensory and autonomic neuropathy (HSAN), amyloidosis, spinal cord injuries (loss of sensation below lesion level), tabes dorsalis, syringomyelia
• Chronic alcoholism: Thiamine deficiency and direct toxicity cause sensorimotor polyneuropathy
• HIV/AIDS-related neuropathy: Antiretroviral drug toxicity (didanosine, stavudine, zalcitabine) or opportunistic infections (CMV, herpes simplex)

Risk factors

• Diabetes duration >10 years
• Poor glycemic control (HbA1c >8%)
• Hypertension and dyslipidemia
• Obesity
• Smoking
• Plantar pressure >6 kg/cm² (high-risk foot)
• Previous foot ulcer or amputation
• Inability to visually inspect feet
• Age >40 years with diabetes

ARTERIAL ULCERS

Cardinal symptoms

• Claudication pain: Cramping, aching, or fatigue in calf (most common) or buttock/thigh muscles during exertion; reproducible at consistent distances (e.g., pain after 100-200 meters); relieved by rest within 5-10 minutes (rest pain threshold increases with progressive PAD)
• Rest pain: Indicates critical limb ischemia (perfusion pressure <50 mmHg); occurs at night or when supine; patient often hangs leg over edge of bed for gravitational blood flow relief ("dependency" position). Severe, burning quality; sleep disruption
• Acute limb-threatening ischemia symptoms: Sudden onset of severe pain, coldness, numbness, or paralysis suggests acute arterial occlusion (medical emergency)
• Claudication absent in some cases: Silent ischemia may occur in diabetics with autonomic neuropathy

Physical examination findings

• Skin appearance: Pale, thin, shiny skin with loss of hair; cyanosis (blue-purple discoloration with dependent rubor); temperature gradient (cool limb; may have line of demarcation between warm and cold skin)
• Ulcer characteristics: Well-demarcated, punched-out appearance with minimal surrounding erythema or edema; located on pressure points or trauma-prone areas (lateral malleolus, tips of toes, heel, dorsum of foot); painful, necrotic base with black/dark brown eschar; minimal granulation tissue or exudate; often termed "gangrene" if full-thickness tissue death
• Pulse examination: Diminished or absent pedal pulses (dorsalis pedis, posterior tibial); diminished femoral, popliteal pulses depending on stenosis location; asymmetric pulses between limbs; bruit suggestive of turbulent flow
• Capillary refill: Delayed (>3 seconds)
• Muscle atrophy: Calf atrophy from disuse and ischemia
• Trophic changes: Shiny, atrophic skin; loss of subcutaneous fat; prominent veins may appear flat due to poor filling
• Allen's test abnormality: Prolonged color return in digital ischemia
• Acute presentation findings: Mottled skin, sensory/motor changes (paresthesias, weakness), muscle tenderness from rhabdomyolysis if acute severe ischemia

VENOUS ULCERS

Cardinal symptoms

• Dull ache or heaviness: In calf or entire leg, worse with prolonged standing, improved with elevation and compression; typically not truly painful unless ulcer is secondarily infected
• Itching: Pruritus of affected limb (hypoxic dermatitis)
• Swelling: Ankle and calf edema, typically unilateral but may be bilateral; worse after ambulation and standing; improves with elevation overnight
• Skin changes: Darkening of skin from hemosiderin deposition (brown discoloration); sensation of tightness

Physical examination findings

• Edema: Pitting ankle edema (worse in evening); may extend to calf or thigh; typically resolves partially with leg elevation
• Skin changes: Hyperpigmentation (hemosiderin deposition causing brown/bronze discoloration), lipodermatosclerosis (induration, fibrosis, "inverted champagne bottle" appearance of lower leg with narrowing above ankle), atrophie blanche (pale, atrophic patches with telangiectasia and loss of hair)
• Varicose veins: Visible distended superficial veins; may be absent if deep venous system is primary problem
• Ulcer characteristics: Shallow, irregular, ill-defined borders; located typically on medial gaiter area (above medial malleolus, on medial lower leg); exudative, beefy-red granulation tissue; minimal pain unless infected; surrounding erythema and edema; may be wet/weeping appearance; multiple ulcers possible
• Calf squeeze sign: Minimal pain with deep calf palpation (distinguishes from arterial ulcers which are very painful)
• Trendelenburg test: Saphenous vein reflux (veins fill from above when standing after leg elevation)
• Perthe's test abnormality: Absence of pressure improvement when tourniquet applied above knee during standing (indicating deep venous obstruction)
• Pitting lymphedema: May coexist, indicating impaired lymphatic drainage
• Signs of post-thrombotic syndrome: Skin changes described above; history of DVT with residual obstruction/reflux

NEUROPATHIC ULCERS

Cardinal symptoms

• Absence of pain: Ulcer often painless despite appearing severe; patient unaware of injury until discovered (silent ulcer); this contrasts starkly with arterial ulcers (very painful) and distinguishes neuropathic ulcers
• History of diabetes or other neuropathic disease: Patient may report progressive numbness in feet, stocking-glove distribution
• Foot symptoms: Tingling, burning, or "walking on cotton" sensation; some patients report paradoxical hyperesthesia or allodynia
• Mechanical symptoms: Blisters, calluses, feeling of foot instability or giving way
• Recurrent ulcers: History of prior foot ulcers or amputation

Physical examination findings

• Loss of protective sensation: Absent vibratory sense (tuning fork 128 Hz) at ankle/toe; impaired temperature discrimination (warm/cold testing); diminished or absent pinprick/light touch in stocking-glove distribution; positive monofilament testing (inability to detect 5.07 g Semmes-Weinstein monofilament at standard sites: first, third, and fifth metatarsal heads, heel, dorsum of foot)
• Motor findings: Diminished or absent reflexes (Achilles reflex absent first); foot weakness; claw toe deformities; atrophy of intrinsic foot muscles
• Ulcer characteristics: Located at high-pressure plantar areas (first and fifth metatarsal heads most common, also heel, midfoot); painless deep ulcer with relatively normal surrounding skin; typically punched-out appearance with callous rim; surrounding erythema minimal unless infected; drainage varies (may be copious if infected); base may have fibrinous tissue or exposed bone; full-thickness ulcers common; multiple ulcers possible
• Skin appearance: Dry, fissured skin (autonomic neuropathy causing anhidrosis); hyperkeratosis with callus formation; blisters; normal temperature (distinguish from cool arterial limb)
• Foot deformities: Charcot foot (severe bone resorption, fractures, deformities from repeated trauma in completely denervated foot); rocker-bottom foot; prominent metatarsal heads; medial arch collapse
• Pulses intact: Normal

Step 1 — bedside vascular screening (all ulcers)

• Ankle-brachial index (ABI): the initial test in any leg ulcer, per the ACC/AHA peripheral artery disease guideline. Highest ankle systolic pressure ÷ highest brachial pressure. ≤0.90 confirms PAD; 0.91–0.99 borderline; 1.00–1.40 normal; >1.40 indicates non-compressible, medially calcified vessels (classically diabetes or ESRD) and is uninterpretable.
• Toe-brachial index (TBI) / toe pressure: obtained when ABI is >1.40 or falsely normal; digital arteries resist medial calcification. TBI <0.70 is abnormal, and very low absolute toe or ankle pressures support chronic limb-threatening ischemia.
• Segmental pressures and pulse-volume recordings localize the level of disease; exercise ABI unmasks disease when resting ABI is normal but claudication is present.

Step 2 — anatomic confirmation

• Arterial: arterial duplex ultrasound, then CTA or MRA; catheter angiography (DSA) remains the gold standard and is reserved for planning revascularization.
• Venous: duplex ultrasound with reflux timing is the confirmatory test — retrograde flow >500 ms in superficial veins or >1000 ms in deep veins defines incompetence; it also identifies post-thrombotic obstruction. Severity is reported by the CEAP classification (C5 = healed ulcer, C6 = active venous ulcer).
• Neuropathic: 10-g Semmes-Weinstein monofilament plus 128-Hz tuning fork documents loss of protective sensation (ADA Standards of Care). Probe-to-bone, plain radiographs, and markedly elevated ESR/CRP raise suspicion for osteomyelitis; MRI is the best imaging test and bone biopsy with culture is the diagnostic gold standard.

Staging and adjuncts

• SVS WIfI system (Wound, Ischemia, foot Infection) stratifies amputation risk and revascularization benefit; Wagner and University of Texas systems grade diabetic foot ulcer depth.
• Wound culture: deep tissue, not superficial swab, and only when clinically infected (IDSA/IWGDF).
• Biopsy the ulcer edge if it fails to heal despite adequate therapy — Marjolin ulcer (squamous cell carcinoma) hides in chronic wounds.

Immediate triage

• Acute limb ischemia or foot sepsis is an emergency: systemic anticoagulation with unfractionated heparin, urgent vascular surgery consultation, and emergent revascularization or debridement. Rapidly spreading infection, crepitus, or hemodynamic instability mandates operative exploration before imaging.

Arterial ulcers (ACC/AHA PAD guideline)

• Risk-factor modification is first-line: complete smoking cessation, high-intensity statin (atorvastatin), antihypertensive therapy, and glycemic control.
• Antiplatelet therapy: single-agent aspirin or clopidogrel. In symptomatic PAD, low-dose rivaroxaban plus aspirin reduces major adverse limb events (COMPASS/VOYAGER PAD data).
• Claudication: supervised exercise therapy first, then cilostazol (phosphodiesterase-3 inhibitor) — contraindicated in any heart failure because PDE-3 inhibitors increase mortality in HF.
• Definitive therapy for chronic limb-threatening ischemia: revascularization — endovascular intervention or surgical bypass (BEST-CLI compared strategies). Wounds will not heal without inflow.
• Contraindicated: high-pressure compression and aggressive debridement of dry, stable eschar in a poorly perfused limb.

Venous ulcers (SVS/American Venous Forum guideline)

• Graded compression therapy is the cornerstone — multilayer bandaging or 30–40 mmHg stockings — but only after arterial disease is excluded by ABI.
• Adjuncts: leg elevation, calf-pump exercise, moist wound dressings, sharp debridement of slough, pentoxifylline as a healing adjunct.
• Definitive: endovenous ablation of incompetent superficial veins in addition to compression accelerates healing and reduces recurrence (EVRA trial); skin grafts/cellular tissue products for refractory ulcers.

Neuropathic/diabetic foot ulcers (ADA and IWGDF/IDSA)

• Offloading is the single most important intervention — total contact casting is the reference standard; removable boots are alternatives.
• Sharp debridement of callus and necrotic tissue, plus glycemic optimization.
• Antibiotics only for clinically infected wounds — never for a clean ulcer solely because cultures grow organisms; cover Staphylococcus and streptococci, broadening for severe or chronic infection.
• Osteomyelitis: prolonged culture-directed antibiotics with or without resection of infected bone.

Infectious (most are emergencies)

• Cellulitis and deep soft-tissue infection: bacterial invasion through the broken barrier; signaled by expanding erythema, warmth, purulence, and systemic signs. In neuropathic feet pain is absent, so fever plus unexplained hyperglycemia may be the only clue.
• Osteomyelitis: contiguous spread through a deep ulcer; suspect with a positive probe-to-bone test, an ulcer >2 cm or persisting despite care, and markedly elevated ESR/CRP. MRI confirms.
• Necrotizing soft tissue infection / gas gangrene: surgical emergency — pain out of proportion, crepitus, bullae, dishwater drainage, rapid systemic toxicity. Requires immediate debridement, not antibiotics alone.
• Sepsis and bacteremia: the ulcer is the portal; hypotension and organ dysfunction demand resuscitation and source control.

Vascular and structural

• Acute limb ischemia superimposed on chronic PAD: thrombosis of a stenotic segment; the 6 Ps (pain, pallor, pulselessness, paresthesia, poikilothermia, paralysis). Emergency — paralysis and anesthesia indicate a threatened, possibly non-salvageable limb.
• Major amputation: the end result of unhealed ischemic or infected wounds; carries high perioperative and long-term cardiovascular mortality.
• Charcot neuroarthropathy: denervated bone with unopposed inflammatory osteolysis; a warm, swollen, erythematous but relatively painless foot that mimics infection, evolving to rocker-bottom deformity and new ulceration.
• Marjolin ulcer: squamous cell carcinoma arising in a chronic wound; heaped-up, everting edges or sudden growth in a long-standing ulcer — biopsy.
• Recurrent DVT and worsening post-thrombotic syndrome in venous disease.

Treatment-related

• Compression applied to an ischemic limb causes pressure necrosis — always check ABI first.
• Total contact cast can create new iatrogenic ulcers over bony prominences in an insensate foot.
• Antithrombotics: bleeding; cilostazol: headache, tachyarrhythmia, and harm in heart failure.
• Angiography: contrast-associated nephropathy and cholesterol embolization (blue toe syndrome, livedo, eosinophilia).
• Topical antibiotics/dressings: allergic contact dermatitis, a common cause of a "failing" venous ulcer.

• Location is the fastest discriminator: medial gaiter area above the medial malleolus = venous; lateral malleolus, toe tips, heel, punched-out and painful = arterial; plantar metatarsal heads with a callus rim and no pain = neuropathic.
• The single best next step in almost any leg ulcer stem is the ABI. It is cheap, non-invasive, and determines whether compression is safe. Order it before starting compression for a presumed venous ulcer.
• ABI >1.40 does not mean healthy arteries — it means non-compressible calcified vessels (diabetes, CKD). The correct follow-up is a toe-brachial index or toe pressure, not reassurance. This is the most common distractor.
• A painless deep ulcer with intact pedal pulses is neuropathic, not arterial. Conversely, dependent rubor with pallor on elevation and night pain relieved by dangling the leg is arterial rest pain.
• Compression is therapeutic in venous disease and dangerous in arterial disease — the exam loves a stem where compression was applied to a patient with a low ABI and the limb worsened.
• Offloading, usually total contact casting, is the key intervention for a diabetic plantar ulcer (ADA/IWGDF). Antibiotics are for clinically infected wounds only; treating a colonized but uninfected ulcer is the wrong answer.
• A positive probe-to-bone test in a diabetic foot ulcer means osteomyelitis until proven otherwise — MRI to image, bone biopsy as gold standard.
• **Hemosiderin hyperpigmentation, lipodermatosclerosis with an inverted champagne bottle leg, and *atrophie blanche* are the venous buzzwords; claudication with a reproducible walking distance is the arterial one; Charcot rocker-bottom foot** is the neuropathic one.
• A chronic ulcer that will not heal despite correct therapy needs an edge biopsy to exclude Marjolin ulcer (squamous cell carcinoma), vasculitis, or pyoderma gangrenosum.